Both medications are weekly injections that work on the hormones tied to hunger, metabolism, and blood sugar
In particular, we observed that the -1 subcluster expressed low levels of ARX , IRX2 , CRYBA2 , ALDH1A1 , and TM4SF4
Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030
Unfortunately, like other GLP1R agonists, retatrutide also produced significant GI side effects in a large proportion of participants (35% in the 36 week study and 45% in the 48 week study at the 12 mg dose) (Rosenstock et al., 2023)
Elevate your beauty and wellness